Theravance Biopharma Inc

TBPH · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

58 USD

Margin of Safety

+70.5 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Theravance Biopharma is a biopharmaceutical company that generates revenue from royalties and the monetization of pharmaceutical patents in the field of inhaled pharmacology, with the business model increasingly oriented in recent times toward portfolio reduction and capital return to shareholders.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.